Abstract
Efficacy of Front-Line Ibrutinib Versus Fludarabine, Cyclophosphamide and Rituximab (FCR) in Patients with CLL. a Multicenter “Real-World” Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have